Results 31 to 40 of about 14,759,288 (215)

Impact of Medical Marijuana Legalization on Opioid use, Chronic Opioid use and High-Risk Opioid use [PDF]

open access: yesValue in Health, 2018
To determine the association of medical marijuana legalization with prescription opioid utilization. A 10% sample of a nationally representative database of commercially insured population was used to gather information on opioid use, chronic opioid use, and high-risk opioid use for the years 2006–2014. Adults with pharmacy and medical benefits for the
AB Shah, CJ Hayes, M Lakkad, BC Martin
openaire   +1 more source

A qualitative study of the impacts of a government crackdown against revenue sharing between pharmacies and patients in Vancouver, Canada

open access: yesDiscover Public Health
Background The city of Vancouver, Canada has been under a public health emergency driven by the unregulated toxic drug supply since April 2016. Interventions implemented during the crisis have often been driven by electoral interests, and in turn ...
Tyson Singh Kelsall   +5 more
doaj   +1 more source

Building capacity for collaborative research on opioid and other substance use disorders through the Clinical and Translational Science Award Program

open access: yesJournal of Clinical and Translational Science, 2020
The opioid crisis in the USA requires immediate action through clinical and translational research. Already built network infrastructure through funding by the National Institute on Drug Abuse (NIDA) and National Center for Advancing Translational ...
Linda B. Cottler   +5 more
doaj   +1 more source

A systematic review of economic evaluations for opioid misuse, cannabis and illicit drug use prevention.

open access: yes, 2023
BACKGROUND: Substance use disorders negatively affect global disease burden. Effective preventive interventions are available, but whether they provide value for money is unclear.
Chatterton, Mary Lou   +14 more
core   +1 more source

Use and misuse of opioid agonists in opioid addiction

open access: yesCleveland Clinic Journal of Medicine, 2017
Although methadone (an opioid agonist) and buprenorphine (a partial opioid agonist) have evidence to support their use in treating opioid use disorder, they remain misunderstood and underutilized. In this article, we outline the risks and benefits of using these drugs as maintenance therapy in opioid-dependent patients.
Vania, Modesto-Lowe   +3 more
openaire   +2 more sources

Chronic postsurgical pain: From risk factor identification to multidisciplinary management at the Toronto General Hospital Transitional Pain Service

open access: yesCanadian Journal of Pain, 2019
Background: Chronic postsurgical pain is a highly prevalent public health problem associated with substantial emotional, social, and economic costs. Aims: (1) To review the major risk factors for chronic postsurgical pain (CPSP); (2) to describe the ...
Joel Katz   +2 more
doaj   +1 more source

Opioid Agonist Therapy Engagement and Crystal Methamphetamine Use : The Impact of Unregulated Opioid Use in Vancouver, Canada

open access: yes, 2022
Background: Crystal methamphetamine use has substantially increased among people who use opioids in recent years, yet the impact of opioid agonist therapy (OAT) on crystal methamphetamine use remains poorly characterized.
Ti, Lianping   +6 more
core   +1 more source

Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015

open access: yesCancer Medicine, 2022
Background Opioid therapy provides essential pain relief for cancer patients. We used the population‐based Surveillance Epidemiology and End Results (SEER) linked with Medicare database to identify the patterns of opioid use and associated factors in ...
Zhanni Lu   +3 more
doaj   +1 more source

Patient-reported outcomes in cannabinoid hyperemesis syndrome patients treated in the emergency department: a pilot study [PDF]

open access: yesClinical and Experimental Emergency Medicine
Objective Abdominal pain is one of the most common emergency department (ED) complaints, with many patients experiencing recurrent episodes due to cannabinoid hyperemesis syndrome (CHS), a syndrome characterized by pain and vomiting in the setting of ...
Ryan Heidish   +6 more
doaj   +1 more source

Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational Study

open access: yesCritical Care Explorations, 2022
OBJECTIVES:. The association between opioid therapy during critical illness and persistent opioid use after discharge is understudied relative to ICU opioid exposure and modifiable risk factors.
Chelsea Wampole, PharmD   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy